Thursday, January 9, 2025
FDA’s draft guidance on diversifying clinical trial data services is a positive step in the right direction, and the agency must continue encouraging diversity in clinical trials. However, more can be done to further bolster the guidance and ensure that it has a real impact on diversifying clinical trial participation. Why is it important to
[ Read More ]Discovering new drugs, developing them, and bringing them to the market is a five-step process. Each step enables crucial functions to be performed that ensure that new drugs are safe and effective. Step 1: Discovery and Development The discovery phase for new drugs is a fascinating one that incorporates many different insights into disease processes
[ Read More ]In 2019, the FDA recommended its most serious warning label for BIOCELL textured breast implants that academic studies linked to a type of cancer known as BIA-ALCL. Two years on from the warning, and a decade after this was discovered, the issue is still unsolved. Healthtech Founder Joan Melendez believes this risk could be mitigated
[ Read More ]
